You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 253 No. 23, June 21, 1985 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Racial Differences in Serum Total Bilirubin Levels in Health and in Disease (Pernicious Anemia)

Ralph Carmel, MD; Edward T. Wong, MD; John M. Weiner, DPH; Cage S. Johnson, MD

JAMA. 1985;253(23):3416-3418.


Abstract

Common usage prescribes a single normal range for serum bilirubin levels. However, we have not only confirmed that men have higher levels than women but have discovered significant racial differences as well. Among 1,538 healthy Americans, blacks had lower mean bilirubin levels than whites of European origin, Latin Americans, and Asians. These racial differences, which were more pronounced among women than men, were maintained in pernicious anemia. Even though bilirubin levels rose in our 174 patients with this disease, they continued to be lower among blacks than among whites and Latin Americans. Moreover, the actual bilirubin level changes caused by pernicious anemia were themselves smaller among blacks. The racial differences, thus, persisted in pernicious anemia despite similar degrees of anemia, whereas the sex differences disappeared. We suggest that the lower serum bilirubin levels in blacks in health and disease do not stem primarily from lower bilirubin production than in whites.

(JAMA 1985;253:3416-3418)



Author Affiliations

From the Departments of Medicine (Drs Carmel, Weiner, and Johnson) and Pathology (Dr Wong), University of Southern California School of Medicine, Los Angeles; and the Los Angeles County-University of Southern California Medical Center, Los Angeles (Drs Carmel, Wong, Weiner, and Johnson).


Footnotes

Reprint requests to Raulston 306, University of Southern California School of Medicine, 2025 Zonal Ave, Los Angeles, CA 90033 (Dr Carmel).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Relationship of Baseline Serum Bilirubin to Efficacy and Toxicity of Single-Agent Irinotecan in Patients With Metastatic Colorectal Cancer
Meyerhardt et al.
JCO 2004;22:1439-1446.
ABSTRACT | FULL TEXT  

Diagnosis and Monitoring of Hepatic Injury. I. Performance Characteristics of Laboratory Tests
Dufour et al.
Clin. Chem. 2000;46:2027-2049.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.